Z-Phe-Leu-OH

Catalog No.: 
ACJIUG351
CAS No.: 
4313-73-9
Molecular Formula: 
C23H28N2O5
Molecular Weight: 
412.49
Z-Phe-Leu-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$94.00In stockInquiry
100g95%$308.00InquiryInquiry
500g95%$1212.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameZ-Phe-Leu-OH
IUPAC Name((benzyloxy)carbonyl)-L-phenylalanyl-L-leucine
MDL No.MFCD00038301
Molecular FormulaC23H28N2O5
Molecular Weight412.49
SMILESO=C(N[C@@H](CC(C)C)C(O)=O)[C@H](CC1=CC=CC=C1)NC(OCC2=CC=CC=C2)=O
InChI KeyIBOXOGVHBFUSFH-PMACEKPBSA-N
SynonymN-CBZ-Phe-Leu | 4-Methyl-2-[[1-Oxo-2-[[Oxo-(Phenylmethoxy)Methyl]Amino]-3-Phenylpropyl]Amino]Pentanoic Acid | 2-[[2-(Benzyloxycarbonylamino)-3-Phenyl-Propanoyl]Amino]-4-Methyl-Valeric Acid
CAS No.4313-73-9
PubChem CID7272330

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJIUG351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7In Stock
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2In Stock
  6. Then
  7. ACJIUG351 route product structure diagram
    ACJIUG3514313-73-9In Stock
Inquiry

2. ACJIUG351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJIUG351 route product structure diagram
    ACJIUG3514313-73-9In Stock
Inquiry

3. ACJIUG351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJIUG351 route product structure diagram
    ACJIUG3514313-73-9In Stock
Inquiry

Comments (0)